You are here » Home » Companies » Company Overview » Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd.

BSE: 524731 Sector: Health care
NSE: N.A. ISIN Code: INE354A01013
BSE LIVE 15:40 | 05 Dec 524.95 -0.95
(-0.18%)
OPEN

529.95

HIGH

529.95

LOW

520.00

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 529.95
PREVIOUS CLOSE 525.90
VOLUME 712
52-Week high 572.50
52-Week low 330.00
P/E 20.90
Mkt Cap.(Rs cr) 244.10
Buy Price 525.00
Buy Qty 73.00
Sell Price 0.00
Sell Qty 0.00
OPEN 529.95
CLOSE 525.90
VOLUME 712
52-Week high 572.50
52-Week low 330.00
P/E 20.90
Mkt Cap.(Rs cr) 244.10
Buy Price 525.00
Buy Qty 73.00
Sell Price 0.00
Sell Qty 0.00

About Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd., a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family, was formed in 1985.Jenburkt is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange.Jenburkt's head quarters is locat...> More

Jenburkt Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   244
EPS - TTM () [*S] 25.12
P/E Ratio (X) [*S] 20.90
Face Value ()   10
Latest Dividend (%)   9.00
Latest Dividend Date 19 Jul 2016
Dividend Yield (%) 1.37
Book Value / Share () [*S] 101.50
P/B Ratio () [*S] 5.17
[*C] Consolidated     [*S] Standalone

Jenburkt Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 28.69 25.18 13.94
Other Income 0.63 0.6 5
Total Income 29.32 25.77 13.78
Total Expenses 21.75 19.93 9.13
Operating Profit 7.56 5.85 29.23
Net Profit 5.03 3.43 46.65
Equity Capital 4.65 4.65 -
> More on Jenburkt Pharmaceuticals Ltd Financials Results

Jenburkt Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Medicamen Biotec 268.80 4.11 282.78
Orchid Pharma 29.20 0.69 259.76
Piraml.Phyto. 94.30 1.18 244.80
Jenburkt Pharma 524.95 -0.18 244.10
Brooks Lab. 142.75 0.74 231.11
Kopran 51.75 0.78 223.82
Mangalam Drugs 140.60 -0.50 222.57
> More on Jenburkt Pharmaceuticals Ltd Peer Group

Jenburkt Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 45.81
Banks/FIs 0.00
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 49.08
Custodians 0.00
Other 5.11
> More on Jenburkt Pharmaceuticals Ltd Share Holding Pattern

Jenburkt Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.55% NA 0.00% 0.02%
1 Month -6.95% NA -3.39% -3.62%
3 Month 46.31% NA -7.65% -7.73%
6 Month 34.10% NA -1.84% -1.12%
1 Year 13.50% NA 2.77% 4.46%
3 Year 590.72% NA 25.72% 30.25%

Jenburkt Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 520.00
529.95
Week Low/High 520.00
563.00
Month Low/High 446.05
573.00
YEAR Low/High 330.00
573.00
All TIME Low/High 1.80
573.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard